Comparison of efficacy of telmisartan with losartan in patients of essential hypertension with cognitive impairment
Keywords:Cognitive impairment, Mini mental status examination, Losartan, Trail making test-part- A, Telmisartan
Background: Hypertension can lead to mild to moderate alteration in the brain structure and function including cognitive functions impairments. Many first line antihypertensive drugs are devoid of producing significant improvement in cognitive functions; in fact some of them worsen cognitive function. Data suggests that angiotensin II receptor antagonist slows the progression of cognitive impairment associated with hypertension. Hence present study was planned to compare the efficacy of telmisartan with losartan in hypertensive patients with cognitive impairment.
Methods: Prospective, randomized, single blind, comparative study was conducted for period of 24 weeks. Study population was enrolled into two groups: group A (losartan 50 mg) and group B (telmisartan 20 mg). Cognitive functions were assessed by mini mental status examination and trail making test part-A. Qualitative data were analysed by using “Fischer’s test” and quantitative data was analysed by using “t test”.
Results: Baseline clinical characteristics of patients receiving losartan and telmisartan did not show significant difference Telmisartan was as effective as losartan in lowering systolic and diastolic blood pressure in patients of essential hypertension. Increase in mini mental status examination score appeared similar in both groups and there was no statistically significant difference (p>0.05) between the two groups at 12 and 24 weeks of therapy. Reduction in trail making test part A score was slightly more among patient receiving losartan but on comparison of two groups reduction in trail making test part A score was not statistically significant (p>0.05) at 12 and 24 weeks of therapy.
Conclusions: Telmisartan is as effective as losartan in controlling blood pressure and improving cognitive function in hypertensive patients with cognitive impairment.
Waldstein SR. The relation of hypertension to cognitive function. Curr Dir Psychol Sci. 2003;12:9-12.
Waldstein SR, Katzel LI, Elias MF. Hypertension and cognitive function. Neuropsychology of cardiovascular disease. 1st ed. New York: Psychology press; 2001:15-36.
Kelley BJ, Petersen RC. Alzheimer’s disease and mild cognitive impairment. Neurol clin. 2007;25:577-609.
Kelleher, Rory J, Soiza RL. Evidence of endothelial dysfunction in the development of alzheimer’s disease: is alzheimer’s a vascular disorder? AMJ Cardiovasc Dis. 2013;3(4):197-226.
Ciobica A, Bild W, Hritcu L, Haulica I. Brain renin-angiotensin system in cognitive function: pre-clinical findings and implications for prevention and treatment of dementia. Acta Neurol Belg. 2009;109:171-80.
Kazama K, Wang G, Frys K, Anrather J, Iadecola C. Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex. AMJ Physiol. 2003;285:1890-99.
Raghavendra V, Chopra K, Kulkarni SK. Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory. Neuropeptides. 1998;32:417-21.
Tripathi KD. Antiadrenergic drugs (adrenergic receptor antagonist) and drugs for glaucoma. essential of medical pharmacology. New Delhi. Jaypee brothers Medical Publishers; 2013:140-57.
Tedesco MA, Ratti G, Mennella S, Manzo G, Grieco M, Rainone AC, et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am J Hypertens. 1999;12:1130-4.
Fogari R, Mugellini A, Zoppi A, Derosa G, Pasotti C, Fogari E, et al. Influence of losartan and atenolol on memory function in very elderly hypertensive patient. J Hum Hypertens. 2003;17:781-5.
Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-98.
Corrigan JD, Hinkeldey MS. Relationships between parts A and B of the trail making test. J Clin Psychol. 1987;43:402-9.
Zhu JR, Bai J, Cai NS. Efficacy and safety of telmisartan versus losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study. Int J Clin Pract. 2004;145:46-9.
Mallion J, Siche J, Lacourcière Y. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens. 1999;13:657-64.
Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study. Ann Neurol. 2005;57:789-94
Bodiga VL, Bodiga S. Renin angiotensin system in cognitive function and dementia. Asian Journal of Neuroscience. 2013;2013:1-18.
Jennings JR, Muldoon MF, Price J, Christie IC, Meltzer CC. Cerebrovascular support for cognitive processing in hypertensive patients is altered by blood pressure treatment. Hypertension. 2008;52:65-71
Silvestrini M, Pasqualetti P, Baruffaldi R, Bartolini M, Handouk Y, Matteis M, et al. Cerebrovascular reactivity and cognition decline in patients with Alzheimer’s disease. Stroke. 2006;37:1010-5.
Fogari R, Mugellini A, Zoppi A, Lazzari P, Destro M, Rinaldi A, et al. Effect of telmisartan/hydrochlorothiazide versus lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. J Hum Hypertens. 2006;20(3):177-85.
Tchekalarova j, Pechlivanova D, Kambourova T, Matsoukas J, Georgiev V. The effect of sarmesin, an angiotensin II analogue on seizure susceptibility, memory function and nociception. Regul Pept. 2003;111:191-7.
Braszko JJ, Kulakowska A, Polecka WK. CGP 42112A antagonism of the angiotensin II and angiotensin II (3-7) facilitation of recall in rats. Pharmacol Res. 1998;38:461-8.
Braszko JJ, Wisneiwski K, Kupryszewski G,Witczuk B. Psychotropic effects of angiotensin II and III in rats: locomotor and exploratory versus cognitive behaviour. Behav Brain Res.1987;25:195-203.
Hanes DS, Weir MR. Usefulness of ARBs and ACE inhibitors in the prevention of vascular dementia in the elderly. Am J Geriatr Cardiol. 2007;16(3):175-82.
Dominik W, Jan J, Braszko. Telmisartan attenuates cognitive impairment caused by chronic stress in rats. Pharmacological reports. 2014;66:436-41.